In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsor

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by AstraZeneca.

AstraZeneca
Abstract Slides/e-posters Video Report ESC TV Interview
 
A new approach to statin treatment: lipid lowering therapy guidelines in the US.
Presenter: C M Ballantyne (Houston,US)
2014
more
 
Appropriate risk stratification in the management of acute coronary syndromes.
Presenter: AJ Budaj (Warsaw,PL)
2013
more
 
Assessing variability of response to antiplatelet therapy: is there a role for platelet function and generic testing in clinical practice.
Presenter: P A Gurbel (Falls Church,US)
2013
more
 
Cardiovascular benefits of low-dose acetylsalicylic acid use, and the consequences of non-adherence.
Presenter: FWA Verheugt (Amsterdam,NL)
2012
more
 
Cardiovascular profile of incretin modulators and sodium-glucose cotransporter 2 inhibitors.
Presenter: J Wilding (Liverpool,GB)
2012
more
 
Clinical case study: treat early, improve outcomes.
Presenter: A Zambon (Padova,IT)
2013
more
 
Closing remarks - Back in Barcelona with PLATO: 5 years of practice, guidelines and controversies.
Presenter: L C Wallentin (Uppsala,SE)
2014
more
 
Combining antiplatelet and anticoagulant therapy: is more necessarily better?
Presenter: C Bode (Freiburg,DE)
2013
more
 
Current challenges treating cardiovascular disease.
Presenter: T R Pedersen (Oslo,NO)
2013
more
 
Differentiating anti-platelet therapies: pharmacological evidence. Discussion.
Presenter: R F Storey (Sheffield,GB)
2015
more

ESC Congress 365 only features resources for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

AstraZeneca AstraZeneca